A Kyoto University team has developed a method to efficiently generate induced pluripotent stem cells that is less likely to lead to tumor development than the conventional method.
iPS cells are able to transform into the cells of any organ.
The new research, representing a step forward in putting iPS cells into practical use in regenerative medicine, was reported in the online version of the Proceedings of the National Academy of the United States of America on Tuesday.
Generally, iPS cells are produced by introducing four types of genes into skin and other cells. However, one of the genes, c-Myc, can cause cancer.
Read the rest of the article: Safer method to develop iPS cells found